Kevan Herold MD
Professor of Immunobiology and of Medicine (Endocrinology); Deputy Director for Translational Science, YCCI; Director, Yale Diabetes Center
Departments & Organizations
Yale Combined Program in the Biological and Biomedical Sciences (BBS): Immunology
Stem Cell Center, Yale: Transcriptional Regulation of Stem and Progenitor Cells
Immunobiology: HTI | Herold Lab
Internal Medicine: Endocrinology: Diabetes Center | Diabetes Research Center
NIH T32 Program
Type 1 diabetes; Immune therapy; Autoimmunity more...
- BS, Pennsylvania State University, 1977
- M.D., Jefferson Medical College, 1979
- Ablamunits V, Henegariu O, Hansen JB, Opare-Addo L, Preston-Hurlburt P, Santamaria P, Mandrup-Poulsen T, and Herold KC. Synergistic reversal of type 1 diabetes in NOD mice with anti-CD3 and IL-1 blockade: evidence of improved immune regulation (in press) Diabetes.
- Akirav E, Lebastchi J, Galvan EM, Henegariu O, Akirav M, Ablamunits V, Lizardi PM, and Herold KC. Detection of beta cell death in diabetes using differentially methylated circulating DNA (in press) Proc Nat'l Acad Sci (USA)